Skyepharma Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Zogenix and Amicus Therapeutics.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2006 | Founding Date 2002 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Emeryville, US HQ Maidenhead, GB | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 2453% increase | Employees 743% increase | Employees 58415% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $4.8m (FY, 2021) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit N/A | Gross profit $561.3m (FY, 2025) |
Net income | Net income N/A | Net income ($227.4m) (FY, 2021) | Net income ($27.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyAmicus Therapeutics
HQ
Philadelphia, US
Employees
584↑ 15% increase
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company